Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl
Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl buy - large image1
Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl buy - image1
Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl buy - image2
Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl buy - image3
Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl buy - image4
Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl buy - image5
Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl buy - image6

Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl

TDS 61 Inquiries

Unit Price:

$100-108/G FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

GUANGZHOU

Brand:

APKX

Packaging:

5 mg/vial&10 mg/vial

Price valid (until):

2028-06-13

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sales manager:  Eira
    whatsapp:+8619304441463
    Email:  sales01@cnspks.com


      Product Detail  


    For Individual Buyers

    Looking for a peptide that works differently from GLP-1 based options? Cagrilintide (CGL5 / CGL10) is a next-generation amylin analog that targets appetite control through a completely different mechanism. While most weight loss peptides focus on GLP-1 receptors, Cagrilintide mimics the natural hormone amylin, which signals to your brain that you are full and slows down how quickly food leaves your stomach. This means you feel satisfied with smaller portions and experience fewer hunger pangs throughout the day. What makes Cagrilintide especially powerful is that it can be used alone or combined with GLP-1 peptides like Semaglutide for even stronger weight loss results. We offer two – 5 mg per vial (CGL5) for $108 and 10 mg per vial (CGL10) for $172 – so you can choose the option that best fits your protocol.

    Key Benefits:

    • Unique amylin-based mechanism – different from GLP-1 peptides

    Powerful appetite suppression and fullness signals

    Slows gastric emptying for longer satiety after meals

    Can be stacked with GLP-1 peptides for enhanced effects

    Note:This is a cosmetic raw material peptide powder for topical use only. Not for injection.

    Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 1

    For Suppliers / Wholesalers

    Cagrilintide (CGL5 / CGL10) represents an emerging category in the weight management peptide market. As an amylin analog, it offers a unique mechanism of action that is distinct from the crowded GLP-1 segment. This differentiation makes it highly valuable for customers looking to stack or alternate with existing GLP-1 products. Its ability to be combined with Semaglutide or Tirzepatide for synergistic effects positions Cagrilintide as a growing market opportunity. We offer 99%+ purity, CAS 1415456-99-3, in two – 5 mg/vial at $108 and 10 mg/vial at $172.

    Why choose us?

    Unique amylin analog – differentiate from standard GLP-1 products

    • Growing demand for stacking combinations

    Stable inventory, from small trials to bulk exports

     Ideal for research institutions and advanced distributors


    Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 2 Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 3 Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 4 Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 5 Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 6 Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 7 Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 8 Shop Cagrilintide (CGL5 / CGL10) | 99%+ High Purity Peptide Powder | 5 mg & 10 mg/vial | CAS 1415456-99-3 | Weight Loss, Appetite Control, Long-Acting Amyl-Detailed Image 9


    Items Specifications
    Product Name Cagrilintide
    Short Name CGL5&CGL10
    CAS 1415456-99-3
    Purity ≥99% (HPLC)
    Vial Size 5 mg/vial&10 mg/vial

    What Is Cagrilintide?

    Cagrilintide is a synthetic peptide that functions as a long-acting amylin analog. Amylin is a natural hormone produced by the pancreas alongside insulin, and it plays an important role in regulating appetite and blood sugar. When you eat, amylin is released and sends signals to your brain that you are full, while also slowing down gastric emptying so food stays in your stomach longer. Cagrilintide is designed to be more potent and longer-lasting than natural amylin, providing sustained appetite suppression with less frequent dosing. What makes Cagrilintide unique is that it works through a completely different receptor pathway than GLP-1 peptides like Semaglutide or Tirzepatide. This means it can be used alone for appetite control or combined with GLP-1 peptides for a synergistic effect that targets weight loss from two angles. CGL5 and CGL10 are our high-purity versions (99%+), supplied as lyophilized powder with CAS 1415456-99-3. We offer two – 5 mg per vial (CGL5) at $108 and 10 mg per vial (CGL10) at $172 – so customers can choose based on their desired protocol length and dosage strength.

    Why Choose Cagrilintide?

    A different mechanism for appetite control. Most weight loss peptides on the market target GLP-1 receptors. Cagrilintide is different – it targets amylin receptors. This unique pathway means it can work for people who have built tolerance to GLP-1 peptides or who want to attack appetite control from a fresh angle.

    Powerful fullness signals. Cagrilintide tells your brain that you are full, and it keeps that signal active for longer. Users typically feel satisfied with smaller meals and experience less desire to snack between meals, making calorie reduction feel natural rather than forced.

    Slows digestion naturally. By slowing gastric emptying, food stays in your stomach longer after you eat. This prolongs the feeling of fullness and reduces the urge to eat again soon after a meal. It is one of the most effective ways to control portion sizes without willpower alone.

    Perfect for stacking with GLP-1 peptides. Because Cagrilintide works through a different receptor pathway, it can be safely combined with GLP-1 based products like Semaglutide or Tirzepatide. This stacking approach targets weight loss through two complementary mechanisms, potentially leading to better results than either peptide alone.

    Frequently Asked Questions (FAQ)

    Q1: Is this a pharmaceutical drug?
    A: No. This is a high-purity raw material peptide powder for research or cosmetic use, not sold as a finished drug.

    Q2: How is Cagrilintide different from Semaglutide?
    A: Cagrilintide works on amylin receptors, while Semaglutide works on GLP-1 receptors. They are completely different mechanisms that both lead to appetite suppression and weight loss. They can also be used together for enhanced effects.

    Q3: Can I use Cagrilintide with other peptides?
    A: Yes. Cagrilintide is often stacked with GLP-1 peptides like Semaglutide or Tirzepatide for synergistic weight loss effects. Always start with lower doses when combining.

    Q4: What is the difference between CGL5 and CGL10?
    A: CGL5 contains 5 mg per vial and costs $108. CGL10 contains 10 mg per vial and costs $172. The 10 mg option is better for longer protocols or higher dosing needs.

    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Certificates

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides

    Location:

    Room 3043, 3rd Floor, Building 15, No. 185 Xinda Road, Wanghailou Street, Hebei District, Tianjin

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

    Certifications:

    .,证书


       公司简介  


    Company Profile
    We are a modern, rapidly growing biopharmaceutical company specializing in the production of pharmaceuticals, biologics, and nutraceuticals. We offer internationally leading healthcare products, chemicals, electronics, and mining machinery. Our innovative, full-cycle production facilities fully comply with GMP and ISO standards. We are committed to providing high-quality, affordable, innovative products to prevent disease and support healthier lifestyles. We optimize scientific innovation and production technologies to enable our customers to better serve their consumers. We provide a comprehensive range of services and products for the pharmaceutical and nutraceutical industries, from custom development and production of active ingredients to finished dosage forms. With our scale and resources, we offer our customers one-stop solutions to help people get, feel, and stay well.
    
  • Inquiry History
    61 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    Australia

    Cagrilintide

    4 MT Mar 9, 2026
    United States

    Cagrilintide

    15 MG Feb 25, 2026
    United States

    Cagrilintide

    10 PCS Dec 27, 2025
    United States

    Cagrilintide

    2 MT Dec 21, 2025
    United States

    Cagrilintide

    100 MG Oct 28, 2025
    United States

    cagrilintide

    2 MT Aug 8, 2025
    Philippines

    Retatrutide

    5 MG Aug 5, 2025
    China

    Cagrilintide

    100 G May 6, 2025
    United States

    cagrilintide

    5 MG Feb 18, 2025
    United States

    Cagrilintide

    3 MT Feb 7, 2025
    United States

    Cagrilintide

    100  Nov 12, 2024
    United States

    Cagrillintide Lyophilized powder

    100 MG Jul 4, 2024
    United States

    Cagrillintide Lyophilized powder

    1000 MG Apr 20, 2024
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.